SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-073278
Filing Date
2023-09-01
Accepted
2023-09-01 16:46:45
Documents
3
Period of Report
2023-09-01

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea184562-6k_tiziana.htm 6-K 19383
2 AT MARKET ISSUANCE SALES AGREEMENT DATED SEPTEMBER 1, 2023 BY AND BETWEEN TIZIAN ea184562ex1-1_tiziana.htm EX-1.1 230469
3 OPINION OF CONYERS DILL & PEARMAN LIMITED ea184562ex5-1_tiziana.htm EX-5.1 10864
  Complete submission text file 0001213900-23-073278.txt   261851
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences Ltd (Filer) CIK: 0001723069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38723 | Film No.: 231233161
SIC: 2834 Pharmaceutical Preparations